Immunotherapeutic potential of blinatumomab-secreting γ9δ2 T Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapeutic potential of blinatumomab-secreting γ9δ2 T Cells

Published:2023-05 Issue: Volume:31 Page:101650
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Wu Shang-Ju,Lin Chien-Ting^ORCID,Liao Cheng Hao,Lin Chun-Ming

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. Chimeric antigen receptor-modified T cells and T cell-engaging bispecific antibodies: different tools for the same job;Schwerdtfeger;Curr. Hematol. Malig. Rep.,2021

2. CAR T cells better than BiTEs;Molina;Blood Adv.,2021

3. BiTEs better than CAR T cells;Subklewe;Blood Adv.,2021

4. Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia;Wu;J. Hematol. Oncol.,2015

5. Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia;Kantarjian;New Eng. J. Med.,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified heated CGMD simulations for discovering stable docked conformations of BiTE antibody against CD3 and CD117/c-kit;Molecular Simulation;2024-07-24

2. Non-Classical HLA Class 1b and Hepatocellular Carcinoma;Biomedicines;2023-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP